Drugs / SNS01-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01435720 | Sep 2011 → Oct 2014 | diffuse large B-cell lymphoma, mantle cell lymphoma, plasma cell leukemia, plasma cell myeloma | Senesco Technologies, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SNS01-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01435720 ↗ |
| Route | Intravenous | “given by intravenous infusion” NCT01435720 ↗ |